Skip to main content
SpringerLink
Log in

The US FDA says there is not sufficient evidence that SSRI use during pregnancy causes PPHN,*

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. Internet Document: 14 Dec 2011. Available from: URL: http://www.fda.gov/

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The US FDA says there is not sufficient evidence that SSRI use during pregnancy causes PPHN,*. React. Wkly. 1383, 4 (2012). https://doi.org/10.2165/00128415-201213830-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213830-00011

Keywords

Search

Navigation